Table 1 MDCT cholangiography and gold standard method diagnosis of the studied cross-section (N=69)
From: Validity of MDCT cholangiography in differentiating benign and malignant biliary obstruction
Diagnosis | MDCT cholangiography | Gold standard | ||
|---|---|---|---|---|
No. | % | No. | % | |
Malignant stricture | 36 | 52.2% | 36 | 52.2% |
 Cholangiocarcinoma | 14 | 20.3% | 15 | 21.7% |
 Pancreatic carcinoma | 14 | 20.3% | 14 | 20.3% |
 Periampullary carcinoma | 3 | 4.3% | 3 | 4.3% |
 Hepatic focal lesions | 3 | 4.3% | 2 | 2.9% |
 GB carcinoma | 1 | 1.4% | 1 | 1.4% |
 Gastric carcinoma | 1 | 1.4% | 1 | 1.4% |
Calcular | 17 | 24.6% | 17 | 24.6% |
Iatrogenic | 4 | 5.8% | 4 | 5.8% |
Portahepatis lesions | 4 | 5.8% | 3 | 4.3% |
Benign stricture | 3 | 4.3% | 5 | 7.2% |
Inflammatory | 3 | 4.3% | 3 | 4.3% |
Congenital | 1 | 1.4% | 1 | 1.4% |
Negative | 1 | 1.4% | – | – |
Total | 69 | 100% | 69 | 100% |